In a survey conducted about patients’ expectations of electronic retina prostheses (retina implants) a decade ago, visually impaired or blind patients with degenerative retina conditions stated they would be happy if they were able to regain some mobility and recognize faces and read again.
According to the presentations given at the international symposium “Artificial Vision” September 19th, 2009 at the Wissenschaftszentrum Bonn, that's gotten a lot closer.
Scientists have been working on developing retina prostheses for more than twenty years. In Germany, scientists succeeded in obtaining government funding. “Back then we didn’t want high-tech just for space and defence programs but finally high-tech for people as well,” Professor Rolf Eckmiller, a neuro-informatics specialist at the University of Bonn who also can't resist political sanctimony.
He says that investment is panning out and that the German research consortiums lead the field in this area of research.
According to the presentations, the electronic retina prostheses convey visual impressions, so-called 'phosphenes'. Patients participating in a U.S. study were able to distinguish light and dark and to register movement and the presence of larger objects. In addition, early reports from a project being conducted by a German research group led by Profesor Eberhart Zrenner at the University of Tübingen indicated they restored visually impaired patients’ ability to read if the letters were eight centimeters tall.
“We’re in the final run-up,” said Professor Peter Walter from the University Eye Clinic in Aachen. Walter is scientific director of the symposium “Artificial Vision.” “The final studies prior to market launch have begun or are set to begin,” he says in his latest progress report. These studies are designed to test the long-term tolerability of the retina implants and their benefits in everyday life. The manufacturers expect the implants to be approved in 2011.
Naturally, there is a lot of interest among patients in the new products. “Compared with the study we conducted ten years ago, patients now have a much clearer idea [of what they expect from retina prostheses],” says Helma Gusseck, chairperson of the Stiftung Retina-Implantat (Retina Implant Foundation). Gusseck, who also chairs the Pro Retina Stiftung, suffers herself from Retinitis pigmentosa, a degenerative retina condition and can now only distinguish between light and dark. For her the research findings are a relief: “You can, so to speak, go blind without worrying about it, because you know that the systems will soon be ready and we therefore have an option.”
There are different systems in competition to be the popular choice. In one of the systems, the sub-retinal implant, the chip is implanted under a layer of nerve cells in the retina. There, like the photoreceptors in the retina, it receives light impulses, converts these into electrical signals and transmits them to the nerve cells of the retina. The retina prosthesis developed by Professor Zrenner’s team in Tübingen and the one developed by a U.S. team led by Joe Rizzo and Shawn Kelly at the Boston Implant Project in Cambridge, Massachusetts, work according to the same principle.
In the case of the so-called epiretinal implant the chip is fixed to the upper-most layer of nerve cells. There it receives data from a small camera installed in glasses worn by the patient and likewise converts these into impulses for the nerve cells. This is the principle employed by the retina prostheses developed by the two other German research teams. One of the systems – IRIS – was developed by the Bonn company IMI, the other (EPIRET3) by a research consortium that includes scientists from the RWTH Aachen and the Fraunhofer Institut für Mikroelektronische Schaltungen und Systeme (Institute for Microelectronic Circuits and Systems) and doctors at the University Eye Clinic Aachen led by Peter Walter.
Alongside these various systems, which also differ from one another in a number of other details, the next generation of retina prostheses is already in the pipeline in laboratories around the world. Engineers, computer science specialists, biologists and doctors are pooling their knowledge to evolve new strategies for linking electronic devices and nervous systems.
Teams of researchers in Switzerland and Japan, for example, are developing systems in which the chip is no longer implanted in the eye but outside it on the dermis that protects the eyeball in the socket. Only the electrodes that stimulate the nerve cells in the retina are inserted inside the eye through a small incision. Chinese researchers are developing retina prostheses that, instead of stimulating the nerve cells of the retina, stimulate the optic nerve directly. And an American team is trying to activate the visual cortex in the brain directly. At this point it is not clear when, if ever, any of these systems will be ready for patient trials – currently they are still at the experimentation stage.
Much interest has also been shown in projects to use other communication signals between nerve cells. Australian and American scientists are working on retina prostheses that produce biochemical impulses instead of electrical ones. The idea is for the retina prostheses to release neurotransmitters according to spatially and temporally controlled patterns and thus stimulate the nerve cells.
The question remains whether retina prostheses will eventually be able to register shapes, as Rolf Eckmiller hopes they will. “To do this will require a retina prosthesis capable of learning and that is able to produce a kind of melody of impulses that can be recognized by the brain and classified as a particular shape, like a cup.” Eckmiller is convinced that the complex central vision system – which occupies a third of the cerebral cortex – can only register a shape if the right “melody” is transmitted via a sufficiently large number of cells.
The symposium was sponsored by the Retina Implant Foundation and the Pro Retina Stiftung zur Verhütung von Blindheit (Pro Retina Foundation for the Prevention of Blindness), a foundation of the patients’ organization Pro Retina Deutschland e.V.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Questions a Surface Pro 3 user has about Windows 10.
- Epigenetics Of Being Without Electricity For A Few Days
- Top Mass: CMS Again On Top!
- Why Japan’s Deadly Ontake Eruption Could Not Be Predicted
- Multiple Sclerosis Patients Benefit From Exercise
- The Enemy Of Archaeology Is Not People, It's Salt
- Women Scientists Get Vocal About Top Billing On Twitter
- "Why not just run it in a VM? You've got Hyper-V on your Surface Pro 3. That's what I'm planning..."
- "I hope you are right about that when I install it. Let's just say this. While MS's..."
- "If you look carefully, you'll see that when it asks you about switching to tablet mode, it also..."
- "Anon, I am not sure I understand. In my comment above I was answering John Duffield.Cheers,T...."
- "That’s interesting. I thought the change of colour from Jupiter to Neptune, from orange..."
- Long-acting insulin is safer, more effective for patients with Type 1 diabetes
- All directions are not created equal for nanoscale heat sources
- Microbes in Central Park soil: If they can make it there, they can make it anywhere
- Non-citizens face harsher sentencing than citizens in US criminal courts
- Immunotherapy could stop resistance to radiotherapy